Clinical Trial Update: The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating EVICEL for soft tissue and parenchymal organ bleeding has completed activity with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage
• Soft Tissue Bleeding

Drugs mentioned

• Evicel

Snippet

Sponsor: Ethicon, Inc. | Conditions: Hemorrhage, Soft Tissue Bleeding | Phase 3 | Status: COMPLETED | Results posted: 2020-08-31